Silicon based drug conjugates and methods of using same
US11291731B2 · kind B2 · utility
0Cited by
7References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 6, 2018 |
| Grant date | Apr 5, 2022 |
| Priority date | — |
| Expiry date | Feb 26, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08G77/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are silicon based conjugates capable of delivering one or more payload moieties to a target cell or tissue. Contemplated conjugates may include a silicon-heteroatom core, one or more optional catalytic moieties, a targeting moiety that permits accumulation of the conjugate within a target cell or tissue, one or more payload moieties (e.g., a therapeutic agent or imaging agent), and two or more non-interfering moieties covalently bound to the silicon-heteroatom core.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.